Product Information
RISEDRONATE SODIUM 35 MG TABLET is a generic product labeled by Apotex Corp., priced at $2.3991 per EA under NDC 60505316500. Its NADAC has been published 542 times since Feb 10, 2016.
Strength
35 mg/1
Manufacturer
Apotex Corp.NDC
60505316500
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RISEDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA090877On Market Since
11/30/2015
Pharmacological Classes
Price Statistics
The NADAC for RISEDRONATE SODIUM 35 MG TABLET has been published 542 times since Feb 10, 2016, and over the history we have for it it has declined 94.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.3991 per EA |
|---|---|
| All-time high | $43.3459 (Feb 10, 2016) |
| All-time low | $1.1853 (Sep 20, 2023) |
| 52-week high | $2.4340 |
| 52-week low | $1.8164 |
| Median price | $4.1688 |
| Average price | $5.7304 |
| Largest weekly change | +76.8% (Dec 20, 2023) |
| Weeks tracked | 542 |
| Tracking since | Feb 10, 2016 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISEDRONATE SODIUM 35 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RISEDRONATE SODIUM 35 MG TABLET, manufactured by Apotex Corp., is $2.3991 per EA (NDC 60505316500), effective Jun 24, 2026.
How has the price of RISEDRONATE SODIUM 35 MG TABLET changed over time?
Over the history we have for it, the NADAC for RISEDRONATE SODIUM 35 MG TABLET has declined 94.5%. It has been tracked across 542 weekly CMS publications since Feb 10, 2016.
What are the highest and lowest recorded NADAC prices for RISEDRONATE SODIUM 35 MG TABLET?
Since Feb 10, 2016, the NADAC for RISEDRONATE SODIUM 35 MG TABLET has ranged from a low of $1.1853 (Sep 20, 2023) to a high of $43.3459 (Feb 10, 2016), with a median of $4.1688 per EA.
Are there cheaper alternatives to RISEDRONATE SODIUM 35 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as RISEDRONATE SODIUM 35 MG TABLET, but none are currently priced below it.
Who manufactures RISEDRONATE SODIUM 35 MG TABLET?
RISEDRONATE SODIUM 35 MG TABLET (NDC 60505316500) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification